Miao Yu

6PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Rural community developmentPharmaceutical delivery technologiesPredictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 17, 2025
Dapagliflozin and chiglitazar combination enhanced myocardial energy metabolism in high-fat diet-fed mice.

Jieying Liu, Jing Zhou, Shunhua Li

|Oct 21, 2025
iGlarLixi: A titrateable fixed-ratio combination of basal insulin + GLP-1 receptor agonist-An effective type 2 diabetes treatment option in China.

Miao Yu

|Oct 14, 2025
Triple oral therapy with metformin, DPP-4 inhibitor, and SGLT2 inhibitor for adults with type 2 diabetes: Consensus recommendations of a Chinese expert panel (version 2025).

Miao Yu, Tong Wang, Chun Xu

|Jun 12, 2023
The Clinical Characteristics and Potential Molecular Mechanism of LMNA Mutation-Related Lipodystrophy.

Cheng Xiao, Jieying Liu, Chunru Yang

|Jun 16, 2021
Factors associated with switching from sulphonylureas to dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in the United States.

Xi Tan, Lingfeng Yang, Kamlesh Khunti

|Sep 29, 2020
Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: An East Asian perspective.

Linong Ji, Juliana C N Chan, Miao Yu

Pageof 1

Frequent Collaborators

1 joint publications

Linong Ji

1 joint publications

Juliana C N Chan

1 joint publications

Kun Ho Yoon

1 joint publications

Sin Gon Kim